California’s Governor Gavin Newsom (D) signed two of several psychedelics and marijuana proposals.
The Bills
AB1021 enables “a physician, pharmacist, or other authorized healing arts licensee acting within their scope of practice” to prescribe and dispense current Schedule I drugs -including the designated “breakthrough therapies” concerning psilocybin and MDMA- once their federal status changes reported Marijuana Moment’s Kyle Jaeger.
See Also: Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal
Meanwhile, AB623 calls on the Dept. of Cannabis Control to amend THC variance testing rules for marijuana products toward developing more “appropriate” ones for cases with lower levels of THC than the specified ones in the existing legislation.
Decision-Pending And Approved Drug Reform Bills
In the psychedelics realm, the proposal noticeably awaiting for the governor’s call is SB58 legalizing adult possession and cultivation of psilocybin, psilocin, DMT and mescaline (with several amendments to the original version.)
In terms of cannabis, the other measures would prevent employers from asking applicants about marijuana use, allow chronically ill patients over 65 to use marijuana at healthcare centers, legalize cannabis cafes, promote sustainable plant tagging and include cannabis packaging and labeling restrictions. More on the bills HERE.
Recently enacted measures grant immunity to people possessing personal use amounts of any controlled substance if they test it for adulterants like fentanyl, show positive tests to law enforcement and inform where they obtained the drug; allow the State Water Board to research for suspected illicit cannabis cultivators and engage in drug enforcement efforts; and modify background-check requirements for cannabis businesses.
Photo: Benzinga edit with photo by 12019 and greenserenityca on Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.